PRESS RELEASE

Q2 2023 — Press release

Q2 2023PDF · 8 pages336 KB
Exhibit 99.1
Media contact 	Investor contact
Timothy Barello, 212.299.2256 	Adam Minick, 312.340.8365
Laurie Bischel, 312.648.8698 	investors@cmegroup.com
news@cmegroup.com 	CME-G
www.cmegroup.com/media-
room.html
FOR IMMEDIATE RELEASE
CME Group Inc. Reports Second-Quarter 2023 Financial Results
• 	Double-digit growth in revenue and adjusted earnings per share
CHICAGO, July 26, 2023 - CME Group Inc. (NASDAQ: CME) today reported financial
results for the second quarter of 2023.
The company reported revenue of $1.4 billion and operating income of $839 million for
the second quarter of 2023. Net income was $778 million and diluted earnings per common
share were $2.14. On an adjusted basis, net income was $836 million and diluted earnings per
common share were $2.30. Financial results presented on an adjusted basis for the second
quarter of 2023 and 2022 exclude certain items, which are detailed in the reconciliation of non-
GAAP results. 1
"Given ongoing uncertainty in both macroeconomic and geopolitical environments,
market participants continued turning to CME Group risk management products and services in
Q2, with particularly noteworthy volume increases across our interest rate, commodity and
options contracts,” said CME Group Chairman and Chief Executive Officer Terry Duffy. "As a
result, we generated a 10% increase in revenue and a 17% rise in adjusted earnings per share,
marking our eighth consecutive quarter of double-digit earnings growth. Looking ahead, we will
remain focused on delivering value to our clients by helping them navigate through what has
become an increasingly unpredictable world."
Second-quarter 2023 average daily volume (ADV) was 22.9 million contracts. Non-U.S.
ADV reached 6.3 million contracts, which included double-digit year-over-year growth in
Agricultural, Metals and Energy products.
1. A reconciliation of the non-GAAP financial results mentioned to the respective GAAP figures can be found within the Reconciliation of
GAAP to non-GAAP Measures chart at the end of the financial statements and earnings presentation materials.
- more -

-- 1 of 8 --

Page 2
Clearing and transaction fees revenue for second-quarter 2023 totaled $1.1 billion. The
total average rate per contract was $0.724. Market data revenue totaled $163 million for
second-quarter 2023.
As of June 30, 2023, the company had approximately $2 billion in cash (including
approximately $120 million deposited with Fixed Income Clearing Corporation, which is included
in other current assets) and $3.4 billion of debt. The company paid dividends of approximately
$400 million during the second quarter of 2023. The company has returned over $21.5 billion to
shareholders in the form of dividends since the implementation of the variable dividend policy in
early 2012.
CME Group will hold a Q&A conference call to discuss second-quarter 2023
results at 8:30 a.m. Eastern Time today. A live audio webcast of the Q&A call will be
available on the Investor Relations section of CME Group’s website at
www.cmegroup.com. An archived recording will be available for up to two months after
the call.
As the world's leading derivatives marketplace, CME Group (www.cmegroup.com) enables clients
to trade futures, options, cash and OTC markets, optimize portfolios, and analyze data - empowering
market participants worldwide to efficiently manage risk and capture opportunities. CME Group
exchanges offer the widest range of global benchmark products across all major asset classes based on
interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The company
offers futures and options on futures trading through the CME Globex® platform, fixed income trading via
BrokerTec and foreign exchange trading on the EBS platform. In addition, it operates one of the world's
leading central counterparty clearing providers, CME Clearing.
CME Group, the Globe logo, CME, Chicago Mercantile Exchange, Globex, and, E-mini are
trademarks of Chicago Mercantile Exchange Inc. CBOT and Chicago Board of Trade are trademarks of
Board of Trade of the City of Chicago, Inc. NYMEX, New York Mercantile Exchange and ClearPort are
trademarks of New York Mercantile Exchange, Inc. COMEX is a trademark of Commodity Exchange, Inc.
BrokerTec and EBS are trademarks of BrokerTec Europe LTD and EBS Group LTD, respectively. The
S&P 500 Index is a product of S&P Dow Jones Indices LLC (“S&P DJI”). “S&P®”, “S&P 500®”, “SPY®”,
“SPX®”, US 500 and The 500 are trademarks of Standard & Poor’s Financial Services LLC; Dow Jones®,
DJIA® and Dow Jones Industrial Average are service and/or trademarks of Dow Jones Trademark
Holdings LLC. These trademarks have been licensed for use by Chicago Mercantile Exchange Inc.
Futures contracts based on the S&P 500 Index are not sponsored, endorsed, marketed, or promoted by
S&P DJI, and S&P DJI makes no representation regarding the advisability of investing in such products.
All other trademarks are the property of their respective owners.
- more -

-- 2 of 8 --

Page 3
Statements in this press release that are not historical facts are forward-looking statements. These
statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are
difficult to predict. Therefore, actual outcomes and results may differ materially from what is expressed or implied
in any forward-looking statements. We want to caution you not to place undue reliance on any forward-looking
statements. We undertake no obligation to publicly update any forward-looking statements, whether as a result of
new information, future events or otherwise. Among the factors that might affect our performance are increasing
competition by foreign and domestic entities, including increased competition from new entrants into our markets
and consolidation of existing entities; our ability to keep pace with rapid technological developments, including our
ability to complete the development, implementation and maintenance of the enhanced functionality required by
our customers while maintaining reliability and ensuring that such technology is not vulnerable to security risks; our
ability to continue introducing competitive new products and services on a timely, cost-effective basis, including
through our electronic trading capabilities, and our ability to maintain the competitiveness of our existing products
and services; our ability to adjust our fixed costs and expenses if our revenues decline; our ability to maintain
existing customers at substantially similar trading levels, develop strategic relationships and attract new customers;
our ability to expand and globally offer our products and services; changes in regulations, including the impact of
any changes in laws or government policies with respect to our products or services or our industry, such as any
changes to regulations and policies that require increased financial and operational resources from us or our
customers; the costs associated with protecting our intellectual property rights and our ability to operate our
business without violating the intellectual property rights of others; decreases in revenue from our market data as a
result of decreased demand or changes to regulations in various jurisdictions; changes in our rate per contract due
to shifts in the mix of the products traded, the trading venue and the mix of customers (whether the customer
receives member or non-member fees or participates in one of our various incentive programs) and the impact of
our tiered pricing structure; the ability of our credit and liquidity risk management practices to adequately protect
us from the credit risks of clearing members and other counterparties, and to satisfy the margin and liquidity
requirements associated with the BrokerTec matched principal business; the ability of our compliance and risk
management programs to effectively monitor and manage our risks, including our ability to prevent errors and
misconduct and protect our infrastructure against security breaches and misappropriation of our intellectual
property assets; our dependence on third-party providers and exposure to risk through third parties, including risks
related to the performance, reliability and security of technology used by our third-party providers and third party
providers that our clients rely on; volatility in commodity, equity and fixed income prices, and price volatility of
financial benchmarks and instruments such as interest rates, credit spreads, equity indices, fixed income
instruments and foreign exchange rates; economic, social, political and market conditions, including the volatility of
the capital and credit markets and the impact of economic conditions on the trading activity of our current and
potential customers; our ability to accommodate increases in contract volume and order transaction traffic and to
implement enhancements without failure or degradation of the performance of our trading and clearing systems;
our ability to execute our growth strategy and maintain our growth effectively; our ability to manage the risks,
control the costs and achieve the synergies associated with our strategy for acquisitions, investments and alliances,
including those associated with the performance of our joint ventures with S&P Dow Jones (S&P Dow Jones Indices
LLC) in index services and in trade processing/post trade services (OSTTRA), our primary data distribution partners’
actions and our partnership with Google Cloud; variances in earnings on cash accounts and collateral that our
clearing house holds for its clients; impact of CME Group pricing and incentive changes; impact of aggregation
services and internalization on trade flow and volumes; any negative financial impacts from changes to the terms of
intellectual property and index rights; uncertainty related to the adoption and growth of SOFR and its impact on our
business; our ability to continue to generate funds and/or manage our indebtedness to allow us to continue to
invest in our business; industry, channel partner and customer consolidation; decreases in trading and clearing

-- 3 of 8 --

activity; the imposition of a transaction tax or user fee on futures and options transactions and/or repeal of the
60/40 tax treatment of such transactions; our ability to maintain our brand and reputation; and the unfavorable
resolution of material legal proceedings. For a detailed discussion and additional information concerning these and
other factors that might affect our performance, see our other recent periodic filings, including our Annual Report
on Form 10-K for the year ended December 31, 2022, as filed with the Securities and Exchange Commission ("SEC")
on February 27, 2023, under the caption "Risk Factors".
# # #

-- 4 of 8 --

CME Group Inc. and Subsidiaries
Consolidated Balance Sheets
(in millions)
June 30, 2023 	December 31, 2022
ASSETS
Current Assets:
Cash and cash equivalents 	$ 	1,880.1 	$ 	2,720.1
Marketable securities 	106.7 	96.0
Accounts receivable, net of allowance 	599.4 	483.2
Other current assets (includes $5.2 and $4.9 in restricted cash) 	538.3 	529.8
Performance bonds and guaranty fund contributions 	113,241.6 	135,249.2
Total current assets 	116,366.1 	139,078.3
Property, net of accumulated depreciation and amortization 	430.1 	455.5
Intangible assets—trading products 	17,175.3 	17,175.3
Intangible assets—other, net 	3,160.3 	3,269.7
Goodwill 	10,490.7 	10,482.5
Other assets (includes $0.0 and $0.1 in restricted cash) 	3,674.2 	3,714.4
Total Assets 	$ 	151,296.7 	$ 	174,175.7
LIABILITIES AND EQUITY
Current Liabilities:
Accounts payable 	$ 	50.9 	$ 	121.4
Short-term debt 	— 	16.0
Other current liabilities 	593.2 	2,300.9
Performance bonds and guaranty fund contributions 	113,241.6 	135,249.2
Total current liabilities 	113,885.7 	137,687.5
Long-term debt 	3,423.8 	3,422.4
Deferred income tax liabilities, net 	5,343.6 	5,361.1
Other liabilities 	825.8 	826.0
Total Liabilities 	123,478.9 	147,297.0
Total CME Group Shareholders’ Equity 	27,817.8 	26,878.7
Total Liabilities and Equity 	$ 	151,296.7 	$ 	174,175.7

-- 5 of 8 --

CME Group Inc. and Subsidiaries
Consolidated Statements of Income
(dollars in millions, except per share amounts; shares in thousands)
Quarter Ended
June 30,
Six Months Ended,
June 30,
2023 	2022 	2023 	2022
Revenues
Clearing and transaction fees 	$ 	1,118.3 	$ 	1,024.6 	$ 2,318.5 	$ 2,162.7
Market data and information services 	163.1 	151.7 	328.9 	303.4
Other 	78.8 	60.9 	154.4 	117.7
Total Revenues 	1,360.2 	1,237.2 	2,801.8 	2,583.8
Expenses
Compensation and benefits 	205.7 	185.3 	410.2 	370.5
Technology 	53.3 	45.9 	104.6 	91.8
Professional fees and outside services 	37.8 	32.0 	76.1 	63.8
Amortization of purchased intangibles 	57.0 	57.1 	113.8 	115.5
Depreciation and amortization 	32.3 	33.0 	64.2 	66.5
Licensing and other fee agreements 	78.2 	83.1 	162.9 	164.0
Other 	57.3 	51.1 	117.7 	102.9
Total Expenses 	521.6 	487.5 	1,049.5 	975.0
Operating Income 	838.6 	749.7 	1,752.3 	1,608.8
Non-Operating Income (Expense)
Investment income 	1,568.2 	286.9 	2,925.9 	360.0
Interest and other borrowing costs 	(40.2) 	(39.9) 	(80.1) 	(82.4)
Equity in net earnings of unconsolidated subsidiaries 	75.1 	87.3 	153.3 	160.6
Other non-operating income (expense) 	(1,425.3) 	(217.3) 	(2,578.1) 	(264.0)
Total Non-Operating Income (Expense) 	177.8 	117.0 	421.0 	174.2
Income before Income Taxes 	1,016.4 	866.7 	2,173.3 	1,783.0
Income tax provision 	238.8 	204.2 	511.9 	409.5
Net Income 	$ 	777.6 	$ 	662.5 	$ 1,661.4 	$ 1,373.5
Net Income Attributable to Common Shareholders of CME
Group 	$ 	767.8 	$ 	654.1 	$ 1,640.5 	$ 1,356.1
Earnings per Share Attributable to Common Shareholders
of CME Group:
Basic 	$ 	2.14 	$ 	1.82 	$ 	4.57 	$ 	3.78
Diluted 	2.14 	1.82 	4.56 	3.78
Weighted Average Number of Common Shares:
Basic 	358,940 	358,641 	358,937 	358,625
Diluted 	359,429 	359,205 	359,371 	359,179

-- 6 of 8 --

CME Group Inc. and Subsidiaries
Quarterly Operating Statistics
2Q 2022 	3Q 2022 	4Q 2022 	1Q 2023 	2Q 2023
Trading Days 	62 	64 	63 	62 	62
Quarterly Average Daily Volume (ADV)(1)
CME Group ADV (in thousands)
Product Line 	2Q 2022 	3Q 2022 	4Q 2022 	1Q 2023 	2Q 2023
Interest rates 	10,630 	10,357 	9,832 	14,490 	11,273
Equity indexes 	7,751 	7,445 	7,465 	7,303 	6,216
Foreign exchange 	950 	1,091 	1,000 	969 	898
Energy 	1,932 	1,837 	1,829 	2,083 	2,104
Agricultural commodities 	1,308 	1,208 	1,171 	1,379 	1,752
Metals 	484 	498 	508 	649 	612
Total 	23,055 	22,437 	21,803 	26,873 	22,855
Venue
CME Globex 	21,531 	21,021 	20,279 	24,171 	20,907
Open outcry 	725 	704 	746 	1,623 	1,124
Privately negotiated 	799 	711 	778 	1,080 	825
Total 	23,055 	22,437 	21,803 	26,873 	22,855
Quarterly Average Rate Per Contract (RPC)(1)
CME Group RPC
Product Line 	2Q 2022 	3Q 2022 	4Q 2022 	1Q 2023 	2Q 2023
Interest rates 	$ 	0.493 	$ 	0.479 	$ 	0.500 	$ 	0.495 	$ 	0.505
Equity indexes 	0.532 	0.524 	0.535 	0.595 	0.644
Foreign 	0.767 	0.729 	0.756 	0.790 	0.800
Energy 	1.171 	1.140 	1.181 	1.300 	1.347
Agricultural commodities 	1.411 	1.351 	1.356 	1.349 	1.356
Metals 	1.506 	1.520 	1.519 	1.517 	1.487
Average RPC 	$ 	0.647 	$ 	0.631 	$ 	0.651 	$ 	0.664 	$ 	0.724
1. ADV and RPC includes futures and options on futures only.

-- 7 of 8 --

CME Group Inc. and Subsidiaries
Reconciliation of GAAP to non-GAAP Measures
(dollars in millions, except per share amounts; shares in thousands)
Quarter Ended
June 30,
Six Months Ended,
June 30,
2023 	2022 	2023 	2022
Net Income 	$ 	777.6 	$ 	662.5 	$ 1,661.4 	$ 1,373.5
Restructuring and severance 	1.6 	6.5 	2.3 	10.2
Amortization of purchased intangibles(1) 	70.5 	68.1 	140.6 	137.9
Strategic transaction-related costs (credits) 	— 	0.6 	(2.2) 	2.2
Foreign exchange transaction (gains) losses 	1.1 	(8.8) 	1.8 	(13.1)
Unrealized and realized (gains) losses on investments 	1.0 	0.5 	(73.8) 	(3.5)
Unrealized and realized (gains) losses on assets 	0.4 	— 	0.4 	—
Debt costs related to refinancing 	— 	— 	— 	7.7
Trading floor enhancements 	— 	0.4 	— 	4.8
Income tax effect related to above 	(15.0) 	(13.0) 	(11.0) 	(28.8)
Other income tax items 	(0.8) 	(0.3) 	(0.8) 	(8.2)
Adjusted Net Income 	$ 	836.4 	$ 	716.5 	$ 1,718.7 	$ 1,482.7
Adjusted Net Income Attributable to Common Shareholders of CME
Group 	$ 	825.9 	$ 	707.5 	$ 1,697.0 	$ 1,464.1
Earnings per Share Attributable to Common Shareholders of CME Group:
Basic 	$ 	2.14 	$ 	1.82 	$ 	4.57 	$ 	3.78
Diluted 	2.14 	1.82 	4.56 	3.78
Adjusted Earnings per Share Attributable to Common Shareholders of CME Group:
Basic 	$ 	2.30 	$ 	1.97 	$ 	4.73 	$ 	4.08
Diluted 	2.30 	1.97 	4.72 	4.08
Weighted Average Number of Common Shares:
Basic 	358,940 	358,641 	358,937 	358,625
Diluted 	359,429 	359,205 	359,371 	359,179
Preferred shares(2) 	4,584 	4,584 	4,584 	4,584
1. Includes $11.0 million of amortization of purchased intangibles (net of tax) at OSTTRA and $2.4 million of amortization of
purchased intangibles at S&P Dow Jones Indices LLC, reported in Equity in net earnings of unconsolidated subsidiaries on the
Consolidated Statements of Income.
2. Preferred shares have similar rights as common shares without voting rights.

-- 8 of 8 --